I 
119TH CONGRESS 
1ST SESSION H. R. 1208 
To amend the Internal Revenue Code of 1986 to deny the trade or business 
expense deduction for the reimbursement of employee costs of child 
gender transition procedure or travel to obtain an abortion. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 11, 2025 
Mr. MAST introduced the following bill; which was referred to the Committee 
on Ways and Means 
A BILL 
To amend the Internal Revenue Code of 1986 to deny the 
trade or business expense deduction for the reimburse-
ment of employee costs of child gender transition proce-
dure or travel to obtain an abortion. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘No Tax Breaks for 
Radical Corporate Activism Act’’. 
SEC. 2. DENIAL OF DEDUCTION. 
(a) IN GENERAL.—Section 162 of the Internal Rev-
enue Code of 1986 is amended by redesignating subsection 
VerDate Sep 11 2014 
22:21 Mar 10, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(s) as subsection (t), and by inserting after subsection (r) 
the following new subsection: 
‘‘(s) DISALLOWANCE OF CERTAIN EXPENSES RELAT-
ING TO ABORTION OR CHILD GENDER TRANSITION.— 
‘‘(1) IN GENERAL.—No deduction shall be al-
lowed under this chapter to an employer for any 
amount paid or incurred to reimburse an employee 
for, or to otherwise pay, expenses in connection 
with— 
‘‘(A) travel for the purpose of obtaining an 
abortion, or 
‘‘(B) any gender transition procedure for a 
minor child of the employee. 
‘‘(2) DEFINITIONS.—For purposes of this sub-
section— 
‘‘(A) GENDER TRANSITION PROCEDURE.— 
‘‘(i) IN GENERAL.—The term ‘gender 
transition procedure’ means any medical or 
surgical service which seeks to alter or re-
move physiological or anatomical charac-
teristics or features which are typical for 
the individual’s biological sex, or to instill 
or create physiological or anatomical char-
acteristics which resemble a sex different 
VerDate Sep 11 2014 
22:21 Mar 10, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
kjohnson on DSK7ZCZBW3PROD with $$_JOB
from the individual’s birth sex, for the pur-
pose of gender transition, including— 
‘‘(I) physician’s services and in-
patient and outpatient hospital serv-
ices, including gender transition sur-
gery, and 
‘‘(II) prescribed drugs related to 
gender transition, including puberty- 
blocking drugs, cross-sex hormones, or 
other mechanisms to promote the de-
velopment 
of 
feminizing 
or 
masculinizing features (in the opposite 
sex). 
‘‘(ii) EXCEPTIONS.—Such term does 
not include— 
‘‘(I) services for treatment of a 
medically verifiable disorder of sex de-
velopment, including— 
‘‘(aa) external biological sex 
characteristics 
which 
are 
irresolvably ambiguous, such as 
the presence of 46 XX chro-
mosomes with virilization, 46 XY 
chromosomes 
with 
VerDate Sep 11 2014 
22:21 Mar 10, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
kjohnson on DSK7ZCZBW3PROD with $$_JOB
undervirilization, or both ovarian 
and testicular tissue, or 
‘‘(bb) other physician-diag-
nosed disorder of sexual develop-
ment, with respect to which the 
physician 
has 
determined 
through genetic or biochemical 
testing that the individual does 
not have normal sex chromosome 
structure, sex steroid hormone 
production, or sex steroid hor-
mone action for a biological male 
or biological female, or 
‘‘(II) treatment of any infection, 
injury, disease, or disorder caused or 
exacerbated by the performance of 
any 
gender 
transition 
procedure, 
whether or not the gender transition 
procedure was performed in accord-
ance with State and Federal law or 
whether not a deduction for expenses 
in connection with the gender transi-
tion procedure is allowable under this 
chapter. 
VerDate Sep 11 2014 
22:21 Mar 10, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
kjohnson on DSK7ZCZBW3PROD with $$_JOB
‘‘(iii) GENDER.—The term ‘gender’ 
means the psychological, behavioral, social, 
and cultural aspects of being male or fe-
male. 
‘‘(iv) 
GENDER
TRANSITION.—The 
term ‘gender transition’ means the process 
in which an individual goes from identi-
fying with and living as a gender that cor-
responds to his or her biological sex to 
identifying with and living as a gender dif-
ferent from his or her biological sex, and 
may involve social, legal, or physical 
changes. 
‘‘(v) 
GENDER
TRANSITION
SUR-
GERY.— 
‘‘(I) IN
GENERAL.—The term 
‘gender transition surgery’ means any 
surgical service, including genital or 
non-genital surgery, performed for the 
purpose of assisting an individual with 
a gender transition. 
‘‘(II) EXCEPTION.—Such term 
does not include any service per-
formed because the individual suffers 
from a physical disorder, physical in-
VerDate Sep 11 2014 
22:21 Mar 10, 2025
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
kjohnson on DSK7ZCZBW3PROD with $$_JOB
jury, or physical illness which would, 
as certified by a physician, place the 
individual in imminent danger of 
death or impairment of major bodily 
function unless surgery is performed. 
‘‘(vi) GENITAL SURGERY.—The term 
‘genital surgery’ includes surgical proce-
dures such as— 
‘‘(I) 
penectomy, 
orchiectomy, 
vaginoplasty, 
clitoroplasty, 
or 
vulvoplasty for biologically male pa-
tients, and 
‘‘(II) hysterectomy, ovariectomy, 
reconstruction of the fixed part of the 
urethra 
with 
or 
without 
a 
metoidioplasty or a phalloplasty, vagi-
nectomy, scrotoplasty, or implantation 
of erection or testicular prostheses for 
biologically female patients. 
‘‘(vii) NON-GENITAL
SURGERY.—The 
term ‘non-genital surgery’ includes surgical 
procedures such as liposuction, lipofilling, 
voice surgery, and— 
‘‘(I) augmentation mammoplasty, 
facial feminization surgery, thyroid 
VerDate Sep 11 2014 
22:21 Mar 10, 2025
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
kjohnson on DSK7ZCZBW3PROD with $$_JOB
cartilage reduction, gluteal augmenta-
tion (whether implants or lipofilling), 
hair reconstruction, or various aes-
thetic procedures for biologically male 
patients, and 
‘‘(II) subcutaneous mastectomy, 
pectoral implants, or various aesthetic 
procedures for biologically female pa-
tients. 
‘‘(viii) PUBERTY-BLOCKING DRUGS.— 
The term ‘puberty-blocking drugs’ means 
gonadotropin-releasing hormone (GnRH) 
analogues or other synthetic drugs used in 
biological males to stop luteinizing hor-
mone secretion and therefore testosterone 
secretion, and synthetic drugs used in bio-
logical females to stop the production of 
estrogen and progesterone, when used to 
delay or suppress pubertal development in 
children for the purpose of assisting an in-
dividual with a gender transition. 
‘‘(ix) CROSS-SEX
HORMONES.—The 
term ‘cross-sex hormones’ means testos-
terone or other androgens given to biologi-
cal females at doses which are profoundly 
VerDate Sep 11 2014 
22:21 Mar 10, 2025
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H1208.IH
H1208
kjohnson on DSK7ZCZBW3PROD with $$_JOB
larger or more potent than would normally 
occur naturally in healthy biological fe-
males, and estrogen given to biological 
males at doses which are profoundly larger 
or more potent than would normally occur 
naturally in healthy biological males. 
‘‘(B) MINOR
CHILD.—The term ‘minor 
child’ means an individual who has not attained 
age 18.’’. 
(b) EFFECTIVE DATE.—The amendments made by 
this section shall apply to taxable years beginning after 
the date of the enactment of this Act. 
Æ 
VerDate Sep 11 2014 
22:21 Mar 10, 2025
Jkt 059200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H1208.IH
H1208
kjohnson on DSK7ZCZBW3PROD with $$_JOB